Teneliximab - AbsoluteAstronomy.com

Teneliximab is a chimeric monoclonal antibody binding to the immune stimulatory protein CD40. , it has not entered clinical trial

Clinical trial

Clinical trials are a set of procedures in medical research and drug development that are conducted to allow safety and efficacy data to be collected for health interventions...

The source of this article is wikipedia, the free encyclopedia. The text of this article is licensed under the GFDL.